Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;136(5 Suppl):72S-75S.
doi: 10.1097/PRS.0000000000001771.

Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Upper Face (Glabella, Forehead, and Crow's Feet)

Gary Monheit  1
Affiliations
Review

Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Upper Face (Glabella, Forehead, and Crow's Feet)

Gary Monheit. Plast Reconstr Surg. 2015 Nov.

Abstract

There are 3 Food and Drug Administration-approved botulinum toxin formulations now being successfully used for treatment in the upper face. The most common areas for botulinum toxin treatment are the upper face, including the glabella, forehead, brows, and lateral canthal lines or crow's feet. The frozen look is no more desired in patients. Thus, physicians are more commonly individualizing dosage based on the patient's variation in anatomy, muscle mass, asymmetry, and, most importantly, desired outcome.

PubMed Disclaimer

References

    1. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21
    1. Carruthers J, Fagien S, Matarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114:1S–22S
    1. Kane MA, Brandt F, Rohrich RJ, et al.Reloxin Investigational Group. Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg. 2009;124:1619–1629
    1. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg. 2007;33:S26–S31

LinkOut - more resources